About Curebase
Curebase is a company based in San Francisco (United States) founded in 2017.. Curebase has raised $59.01 million across 4 funding rounds from investors including Gilead, Industry Ventures and Acrew Capital. Curebase offers products and services including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC. Curebase operates in a competitive market with competitors including L7 Informatics, MDClone, Clinical Research IO, THREAD and VivoSense, among others.
- Headquarter San Francisco, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Curebase, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$59.01 M (USD)
in 4 rounds
-
Latest Funding Round
$40 M (USD), Series B
May 05, 2022
-
Investors
Gilead
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curebase
Curebase offers a comprehensive portfolio of products and services, including ePRO/eCOA, eConsent, Unified Participant Experience, and EDC. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Tools for electronic patient-reported outcomes in clinical trials.
Platform for paperless consent in multi-device clinical studies.
Integrated mobile system for study prescreening and data submission.
Unified platform for hybrid study data management and monitoring.
Unlock access to complete
Funding Insights of Curebase
Curebase has successfully raised a total of $59.01M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $40 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $40.0M
-
First Round
First Round
(22 Aug 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series B - Curebase | Valuation | Industry Ventures | |
| Apr, 2021 | Amount | Series A - Curebase | Valuation | GGV Capital | |
| Oct, 2018 | Amount | Series A - Curebase | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Curebase
Curebase has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Gilead, Industry Ventures and Acrew Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in private tech ecosystem are made by Industry Ventures.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by Acrew Capital venture firm.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on SaaS, mobile tech, AI, and multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Curebase
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Curebase
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Curebase Comparisons
Competitors of Curebase
Curebase operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as L7 Informatics, MDClone, Clinical Research IO, THREAD and VivoSense, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Clinical trial workflow management software is provided for laboratories.
|
|
| domain | founded_year | HQ Location |
Provider of software that creates synthetic medical records for fictitious patients
|
|
| domain | founded_year | HQ Location |
Clinical trial management software is provided for research sites.
|
|
| domain | founded_year | HQ Location |
Provider of patient research studies software
|
|
| domain | founded_year | HQ Location |
Wearable sensor research analysis platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Curebase
Frequently Asked Questions about Curebase
When was Curebase founded?
Curebase was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Where is Curebase located?
Curebase is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Curebase?
Storm Stillman is the current CEO of Curebase.
Is Curebase a funded company?
Curebase is a funded company, having raised a total of $59.01M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.51M, raised on Aug 22, 2018.
What does Curebase do?
Curebase was founded in 2017 in San Francisco, United States, within the clinical research sector. A platform is operated to facilitate patient enrollment and engagement for decentralized trials. Eligibility screening, enrollment processes, participant education, and consent management are streamlined. In-app guidance on protocols is delivered to users, alongside capabilities for document scanning and upload. Operations focus on enhancing trial conduction efficiency.
Who are the top competitors of Curebase?
Curebase's top competitors include L7 Informatics, Sonrai Analytics and MDClone.
What products or services does Curebase offer?
Curebase offers ePRO/eCOA, eConsent, Unified Participant Experience, and EDC.
Who are Curebase's investors?
Curebase has 10 investors. Key investors include Gilead, Industry Ventures, Acrew Capital, World Innovation Lab, and Positive Sum.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.